In our results, patients with NAFLD also complicated with hepatolithiasis, the AST and ALT were significantly higher in NAFLD group than non-NAFLD group, which means in the case of liver enzyme damage, the use of conventional scoring systems such as FIB-4 and NFS for the estimation of advanced fibrosis is limited. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.